EFFECTS OF OVARIECTOMY AND ESTROGEN ON THE SERUM LEVELS OF INSULIN-LIKE GROWTH-FACTOR-I AND INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3

被引:87
|
作者
KALU, DN
ARJMANDI, BH
LIU, CC
SALIH, MA
BIRNBAUM, RS
机构
[1] VET ADM MED CTR,TACOMA,WA 98493
[2] UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195
来源
BONE AND MINERAL | 1994年 / 25卷 / 02期
关键词
IGF-I; IGFBP-3; OVARIECTOMY; 17-BETA-ESTRADIOL; OSTEOBLASTS; OSTEOCLASTS;
D O I
10.1016/S0169-6009(08)80255-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To determine the effects of ovariectomy and 17 beta-estradiol (E(2)) on serum IGF-I and its binding proteins, female Sprague-Dawley rats, aged 95 days, were divided into four groups. Group 1 was sham-operated; groups 2, 3, and 4 were ovariectomized. Groups 3 and 4 received daily injections of 200 ng (low dose) and 5000 ng (high dose) E(2)/kg body wt./day, respectively and the others were given solvent vehicle. Ovariectomy resulted in a significant increase in serum IGF-I (P < 0.001) at 30 and 35 days post-surgery; the increase was prevented in animals that received low-dose E(2) while high-dose E(2) reduced serum IGF-I levels below those of the sham-operated controls (P < 0.01). Serum IGF-binding proteins (IGFBPs) were determined by IGF-ligand blot analysis, and the resulting autoradiograms quantified by laser densitometry. The intensity of the IGFBP-3 bands changed in parallel with serum IGF-I levels. Ovariectomy increased, low-dose E(2) restored, and high-dose E(2) reduced serum IGFBP-3 levels compared to the levels for the sham-operated controls. The intensities of binding protein bands smaller than those of IGFBP-3 appeared unchanged by the treatment regimens. A Western immunoblot analysis with IGFBP-3 antiserum confirmed the ligand-blot data. The changes in the levels of IGF-I and its binding proteins were accompanied by ovariectomy-induced increase in osteoblast and osteoclast numbers and loss of cancellous bone that were attenuated by E(2) administration. We conclude that there is a possible role for IGF-I in the pathogenesis of the increased bone turnover that occurs early in ovarian hormone deficiency.
引用
收藏
页码:135 / 148
页数:14
相关论文
共 50 条
  • [21] Serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 are not useful markers of prostate cancer
    Zancan, M.
    Dittadi, R.
    Scattoni, V.
    Fandella, A.
    Del Bianco, P.
    Gion, M.
    EJC SUPPLEMENTS, 2007, 5 (08): : 36 - 36
  • [22] Serum concentrations of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in patients with chronic hepatitis
    Okan, A
    Çömlekçi, A
    Akpmar, H
    Okan, I
    Yesil, S
    Tankurt, E
    Simsek, I
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2000, 35 (11) : 1212 - 1215
  • [23] Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: Quality control for studies of stored serum
    Berrigan, David
    Potischman, Nancy
    Dodd, Kevin W.
    Nicar, Michael
    McQuillan, Geraldine
    Lavigne, Jackie A.
    Barrett, J. Carl
    Ballard-Barbash, Rachel
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (05) : 1017 - 1022
  • [24] Reference values for serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in Korean children and adolescents
    Hyun, Sei Eun
    Lee, Byung Churl
    Suh, Byung Kyu
    Chung, So Chung
    Ko, Cheol Woo
    Kim, Heung Sik
    Lee, Kee Hyoung
    Yang, Sei Won
    Shin, Choong Ho
    Hwang, Jin Soon
    Kim, Duk Hee
    Lim, Baek Keun
    Kim, Jong Duck
    Yoo, Han-Wook
    Kim, Hye Soon
    Chung, Woo Yeong
    Park, Mi Jung
    Woo, Young Jong
    Kim, Chan Jong
    Lee, Dae-Yeol
    Kim, Eun Young
    Choi, Jin Ho
    Han, Heon Seok
    Hwang, Il Tae
    Kim, Ho-Seong
    CLINICAL BIOCHEMISTRY, 2012, 45 (1-2) : 16 - 21
  • [25] Serum levels of insulin-like growth factor- I and insulin-like growth factor binding protein-3 in relapsing and secondary progressive multiple sclerosis
    Lanzillo, R.
    Di Somma, C.
    Quarantelli, M.
    Gasperi, M.
    Ventrella, G.
    Prinster, A.
    Vacca, G.
    Orefice, G.
    Colao, A.
    Morra, V. Brescia
    JOURNAL OF NEUROLOGY, 2010, 257 : S222 - S222
  • [26] Insulin-Like Growth Factor-I and Insulin-Like Growth Factor Binding Protein-3 in Alzheimer's Disease
    Duron, Emmanuelle
    Funalot, Benoit
    Brunel, Nadege
    Coste, Joel
    Quinquis, Laurent
    Viollet, Cecile
    Belmin, Joel
    Jouanny, Pierre
    Pasquier, Florence
    Treluyer, Jean-Marc
    Epelbaum, Jacques
    le Bouc, Yves
    Hanon, Olivier
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (12): : 4673 - 4681
  • [27] EFFECTS OF DIETARY INSULIN-LIKE GROWTH-FACTOR-I ON GROWTH AND INSULIN-LIKE GROWTH-FACTOR RECEPTORS IN NEONATAL CALF INTESTINE
    BAUMRUCKER, CR
    HADSELL, DL
    BLUM, JW
    JOURNAL OF ANIMAL SCIENCE, 1994, 72 (02) : 428 - 433
  • [28] Impaired sensitivity to insulin and insulin-like growth factor-I in insulin-like growth factor binding protein-3 transgenic mice
    Silha, JV
    Gui, Y
    Murphy, LJ
    DIABETOLOGIA, 2002, 45 : A31 - A31
  • [29] Associations of serum carotenoid levels with serum insulin-like growth factor-I and insulin-like growth factor binding protein-3 levels in black men and white men
    Kim, Young L.
    Jacobs, David R., Jr.
    Gross, Myron D.
    Bergan, Raymond C.
    Gann, Peter H.
    Liu, Kiang
    Gapstur, Susan M.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (12) : 2781 - 2783
  • [30] INSULIN-LIKE GROWTH-FACTOR-I SIGNALING THROUGH HETERODIMERS OF INSULIN AND INSULIN-LIKE GROWTH-FACTOR-I RECEPTORS
    TAKATA, Y
    KOBAYASHI, M
    DIABETES & METABOLISM, 1994, 20 (01): : 31 - 36